TABLE 1.
Characteristic | Value |
---|---|
Total no. | 130 |
Sex | |
Men | 83 |
Women | 47 |
Age (y) | 58.6 ± 13.3 (19–86) |
Plasma glucose (mg/dL) | |
First scan | 100.7 ± 15.8 (63–158) |
Second scan | 98.9 ± 16.4 (62–154) |
FDG dose (mBq) | |
First scan | 606.8 ± 155.4 (321.9–939.8) |
Second scan | 595.7 ± 148.0 (284.9–943.5) |
Weight (kg) | |
First scan | 74.2 ± 19.7 (41–159) |
Second scan | 74.9 ± 19.1 (32–159) |
Height (cm) | 172.1 ± 11.4 (134–198) |
Uptake time | |
First scan | 65.7 ± 15.9 (51–182) |
Second scan | 65.5 ± 13.5 (39–125) |
Elapsed time between scanning (d) | 235.4 ± 192.1 (33–1105) |
Patients scanned on Discovery LSa | 48 (37) |
Patients scanned on Discovery STa | 31 (24) |
Patients scanned once on each scannera | 51 (39) |
Note—Except where indicated otherwise, data are mean ± SD with range in parentheses. Discovery LS and Discovery ST are manufactured by GE Healthcare.
Data are number with percentage in parentheses.